CollPlant Biotechnologies (CLGN) Share-based Compensation Growth (3y) (2021 - 2025)
CollPlant Biotechnologies (CLGN) Share-based Compensation Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.85% |
| Sep 30, 2025 | -25.43% |
| Jun 30, 2025 | -15.93% |
| Dec 31, 2024 | -47.43% |
| Sep 30, 2024 | 50.36% |
| Jun 30, 2024 | 1.47% |
| Mar 31, 2024 | -15.75% |
| Dec 31, 2023 | -30.42% |
| Sep 30, 2023 | 11.78% |
| Jun 30, 2023 | -33.36% |
| Mar 31, 2023 | 51.50% |
| Dec 31, 2022 | -20.42% |
| Sep 30, 2022 | 241.36% |
| Jun 30, 2022 | 27.14% |
| Mar 31, 2022 | 10.68% |
| Dec 31, 2021 | 150.37% |
| Sep 30, 2021 | -54.50% |
| Jun 30, 2021 | 18.48% |
| Mar 31, 2021 | 14.28% |